SciClone Pharmaceuticals is a specialty pharmaceutical company with its primary focus in China. The company’s product portfolio includes therapies for oncology, infectious diseases and disorders of the cardiovascular, urological, respiratory and central nervous systems. Headquartered in Foster City, Calif., SciClone … Continue reading →

Orexigen Therapeutics, a biopharmaceutical company, is focused on treating obesity. Contrave, Orexigen’s lead product candidate, has completed Phase III clinical trials, and a New Drug Application has been submitted and reviewed by the U.S. Food and Drug Administration. The company … Continue reading →

Immunovaccine is a clinical-stage vaccine development company focused on the advancement of its patented DepoVax vaccine adjuvanting platform and product candidates for cancer therapy, infectious disease and animal health. Demonstrating safety and immunogenicity potential, Immunovaccine has advanced its platform technology … Continue reading →

iCo Therapeutics is a re-profiling company engaged in re-dosing or reformulating drugs with clinical history for new or expanded indications. The company owns the global rights to three products: iCo-007, currently in a Phase I trial in diabetic macular edema … Continue reading →

BioDelivery Sciences International is a specialty pharmaceutical company leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize new applications of proven therapeutics – either independently or in partnerships with third parties. The company is currently focused … Continue reading →

Oragenics is dedicated to becoming a global leader in probiotics for oral health in humans and pets and in novel antibiotics against infectious disease. The company is engaged in developing, marketing and selling proprietary probiotics under the brand names Evora … Continue reading →

Arena Pharmaceuticals is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs for weight management, cardiovascular disease, inflammation and other disorders. The company’s internally discovered drug, BELVIQ (lorcaserin HCI), was approved by the U.S. FDA in … Continue reading →

Alkermes is a fully integrated, worldwide biopharmaceutical company focused on applying its scientific expertise and proprietary technologies in the development of innovative medicines to improve patient outcomes. Headquartered in Dublin, Ireland, the company has a diversified portfolio including more than … Continue reading →

OncoGenex Pharmaceuticals is a biopharmaceutical company dedicated to developing and commercializing new therapies to address treatment resistance in cancer patients. Each product candidate in the company’s diverse oncology pipeline has a distinct mechanism of action and represents a unique opportunity … Continue reading →